{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:12:23Z","timestamp":1792098743691,"version":"4.4.0"},"reference-count":166,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Stroke is a major cause of death and disability worldwide. Endovascular thrombectomy has been impactful in decreasing mortality. However, many clinical results continue to show suboptimal functional outcomes despite high recanalization rates. This gap in recanalization and symptomatic improvement suggests a need for adjunctive therapies in post-thrombectomy care. With greater insight into ischemia-reperfusion injury, recent preclinical testing of neuroprotective agents has shifted towards preventing oxidative stress through upregulation of antioxidants and downstream effectors, with positive results. Advances in multiple neuroprotective therapies, including uric acid, activated protein C, nerinetide, otaplimastat, imatinib, verapamil, butylphthalide, edaravone, nelonemdaz, ApTOLL, regional hypothermia, remote ischemic conditioning, normobaric oxygen, and especially nuclear factor erythroid 2-related factor 2, have promising evidence for improving stroke care. Sedation and blood pressure management in endovascular thrombectomy also play crucial roles in improved stroke outcomes. A hand-in-hand approach with both endovascular therapy and neuroprotection may be the key to targeting disability due to stroke.<\/jats:p>","DOI":"10.3390\/ijms25020891","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T05:24:12Z","timestamp":1704950652000},"page":"891","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Neuroprotection during Thrombectomy for Acute Ischemic Stroke: A Review of Future Therapies"],"prefix":"10.3390","volume":"25","author":[{"given":"Vikalpa","family":"Dammavalam","sequence":"first","affiliation":[{"name":"Department of Neurology, Stony Brook University Hospital, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayedatun","family":"Nessa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Stony Brook University Hospital, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Daksla","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Stefanowski","sequence":"additional","affiliation":[{"name":"Department of Neurology, Stony Brook University Hospital, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-6194","authenticated-orcid":false,"given":"Ana","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Bergese","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/17474930211065917","article-title":"World Stroke Organization (WSO): Global Stroke Fact Sheet 2022","volume":"17","author":"Feigin","year":"2022","journal-title":"Int. J. Stroke"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/STROKEAHA.117.019379","article-title":"Implications of Recent Clinical Trials and Hypertension Guidelines on Stroke and Future Cerebrovascular Research","volume":"49","author":"Lackland","year":"2018","journal-title":"Stroke"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kuriakose, D., and Xiao, Z. (2020). Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207609"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5114\/fn.2021.112007","article-title":"Risk factors for ischemic stroke: Differences between cerebral small vessel and large artery atherosclerosis aetiologies","volume":"59","author":"Shi","year":"2021","journal-title":"Folia Neuropathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1177\/0271678X18800589","article-title":"The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation","volume":"38","author":"Cipolla","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e051121189015","DOI":"10.2174\/1573403X16999201210200342","article-title":"Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review","volume":"17","author":"Alloubani","year":"2021","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/CIRCRESAHA.116.308407","article-title":"Cardioembolic Stroke","volume":"120","author":"Kamel","year":"2017","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0041-1726332","article-title":"Atrial Fibrillation and Ischemic Stroke: A Clinical Review","volume":"41","author":"Migdady","year":"2021","journal-title":"Semin. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cjca.2014.01.007","article-title":"Hypertension as a risk factor for ischemic stroke in women","volume":"30","author":"Gorgui","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e000279","DOI":"10.1136\/openhrt-2015-000279","article-title":"NOACs versus warfarin for stroke prevention in patients with AF: A systematic review and meta-analysis","volume":"3","author":"Hicks","year":"2016","journal-title":"Open Heart"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2015.17.1.2","article-title":"Lacunar infarction and small vessel disease: Pathology and pathophysiology","volume":"17","author":"Caplan","year":"2015","journal-title":"J. Stroke"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s001340050625","article-title":"Mortality of space-occupying (\u2018malignant\u2019) middle cerebral artery infarction under conservative intensive care","volume":"24","author":"Berrouschot","year":"1998","journal-title":"Intensive Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1161\/STROKEAHA.107.505776","article-title":"Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier","volume":"39","author":"Gorelick","year":"2008","journal-title":"Stroke"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1385\/NCC:4:1:014","article-title":"Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia","volume":"4","author":"Smith","year":"2006","journal-title":"Neurocrit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archneur.1973.00490300037004","article-title":"Reversibility of ischemic brain damage","volume":"29","author":"Hossmann","year":"1973","journal-title":"Arch. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.STR.5.3.355","article-title":"The distribution and density of reduced cerebral blood flow following acute middle cerebral artery occlusion: An experimental study by the technique of hydrogen clearance in baboons","volume":"5","author":"Symon","year":"1974","journal-title":"Stroke"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/1747493020975229","article-title":"The ischemic penumbra: From concept to reality","volume":"16","author":"Ermine","year":"2021","journal-title":"Int. J. Stroke"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.STR.8.1.51","article-title":"Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia","volume":"8","author":"Astrup","year":"1977","journal-title":"Stroke"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1212\/WNL.0000000000012794","article-title":"Overview of Imaging Modalities in Stroke","volume":"97","author":"Czap","year":"2021","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/STROKEAHA.112.660548","article-title":"Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke","volume":"43","author":"Campbell","year":"2012","journal-title":"Stroke"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1161\/STROKEAHA.108.192616","article-title":"Recommendations for imaging of acute ischemic stroke: A scientific statement from the American Heart Association","volume":"40","author":"Latchaw","year":"2009","journal-title":"Stroke"},{"key":"ref_27","first-page":"1061","article-title":"Clinical experience with diffusion-weighted MR in patients with acute stroke","volume":"19","author":"Laubach","year":"1998","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Vupputuri, A., Ashwal, S., Tsao, B., Haddad, E., and Ghosh, N. (2017, January 11\u201315). MRI based objective ischemic core-penumbra quantification in adult clinical stroke. Proceedings of the 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Jeju, Republic of Korea.","DOI":"10.1109\/EMBC.2017.8037491"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ana.21130","article-title":"Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients","volume":"61","author":"Tan","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/01.STR.0000227243.96808.53","article-title":"Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements","volume":"37","author":"Murphy","year":"2006","journal-title":"Stroke"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1161\/STROKEAHA.109.566869","article-title":"Mismatch-based delayed thrombolysis: A meta-analysis","volume":"41","author":"Mishra","year":"2010","journal-title":"Stroke"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/STROKEAHA.109.571943","article-title":"Clinical outcomes in middle cerebral artery trunk occlusions versus secondary division occlusions after mechanical thrombectomy: Pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials","volume":"41","author":"Shi","year":"2010","journal-title":"Stroke"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"The Penumbra Pivotal Stroke Trial Investigators (2009). The penumbra pivotal stroke trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke, 40, 2761\u20132768.","DOI":"10.1161\/STROKEAHA.108.544957"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"i35","DOI":"10.1136\/jnis.2010.002600.rep","article-title":"The POST trial: Initial post-market experience of the Penumbra system: Revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe","volume":"10","author":"Tarr","year":"2018","journal-title":"J. Neurointerv. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archneur.1996.00550040037012","article-title":"\u2018Malignant\u2019 middle cerebral artery territory infarction: Clinical course and prognostic signs","volume":"53","author":"Hacke","year":"1996","journal-title":"Arch. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ash, M., Dimisko, L., Chalhoub, R.M., Howard, B.M., Cawley, C.M., Matouk, C., Pabaney, A., Spiotta, A.M., Jabbour, P., and Maier, I. (2023). Comprehensive analysis of the impact of procedure time and the \u2018golden hour\u2019 in subpopulations of stroke thrombectomy patients. J. Neurointerv. Surg.","DOI":"10.1136\/jnis-2023-020792"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3174\/ajnr.A6556","article-title":"A Critical Assessment of the Golden Hour and the Impact of Procedural Timing in Stroke Thrombectomy","volume":"41","author":"Wessell","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/neurintsurg-2013-010726","article-title":"The golden hour of stroke intervention: Effect of thrombectomy procedural time in acute ischemic stroke on outcome","volume":"6","author":"Spiotta","year":"2014","journal-title":"J. Neurointerv. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1161\/STROKEAHA.110.583815","article-title":"The \u201cgolden hour\u201d and acute brain ischemia: Presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset","volume":"41","author":"Saver","year":"2010","journal-title":"Stroke"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995). Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med., 333, 1581\u20131587.","DOI":"10.1056\/NEJM199512143332401"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.STR.31.4.811","article-title":"The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): Results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators","volume":"31","author":"Clark","year":"2000","journal-title":"Stroke"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/STROKEAHA.111.645986","article-title":"Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial","volume":"43","author":"Khoury","year":"2012","journal-title":"Stroke"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke","volume":"378","author":"Campbell","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12975-021-00916-2","article-title":"Four Decades of Ischemic Penumbra and Its Implication for Ischemic Stroke","volume":"12","author":"Yang","year":"2021","journal-title":"Transl. Stroke Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1161\/STROKEAHA.109.192535","article-title":"Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American Heart Association\/American Stroke Association","volume":"40","author":"Saver","year":"2009","journal-title":"Stroke"},{"key":"ref_48","first-page":"208","article-title":"Arterial status after intravenous TPA therapy for ischaemic stroke. A need for further interventions","volume":"20","author":"Christou","year":"2001","journal-title":"Int. Angiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3340\/jkns.2022.0120","article-title":"Recanalization Rate and Clinical Outcomes of Intravenous Tissue Plasminogen Activator Administration for Large Vessel Occlusion Stroke Patients","volume":"66","author":"Lee","year":"2023","journal-title":"J. Korean Neurosurg. Soc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.STR.0000258112.14918.24","article-title":"The impact of recanalization on ischemic stroke outcome: A meta-analysis","volume":"38","author":"Rha","year":"2007","journal-title":"Stroke"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","article-title":"Randomized assessment of rapid endovascular treatment of ischemic stroke","volume":"372","author":"Goyal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke","volume":"372","author":"Saver","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","article-title":"Thrombectomy within 8 hours after symptom onset in ischemic stroke","volume":"372","author":"Jovin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJMoa1713973","article-title":"Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging","volume":"378","author":"Albers","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1706442","article-title":"Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct","volume":"378","author":"Nogueira","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(21)01341-6","article-title":"Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): A systematic review and individual patient data meta-analysis","volume":"399","author":"Jovin","year":"2022","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMoa2207576","article-title":"Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion","volume":"387","author":"Jovin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1056\/NEJMoa2206317","article-title":"Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion","volume":"387","author":"Tao","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"svn-2022","DOI":"10.1136\/svn-2022-001740","article-title":"Endovascular treatment for basilar artery occlusion: A meta-analysis","volume":"8","author":"Xu","year":"2023","journal-title":"Stroke Vasc. Neurol"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5853\/jos.2022.03755","article-title":"Endovascular versus Medical Management of Acute Basilar Artery Occlusion: A Systematic Review and Meta-Analysis of the Randomized Controlled Trials","volume":"25","author":"Abdalkader","year":"2023","journal-title":"J. Stroke"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejim.2022.12.011","article-title":"Efficacy of endovascular therapy for basilar and vertebral artery occlusion: A systematic review and meta-analysis of randomized controlled trials","volume":"110","author":"Lin","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa2118191","article-title":"Endovascular Therapy for Acute Stroke with a Large Ischemic Region","volume":"386","author":"Yoshimura","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJMoa2213379","article-title":"Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct","volume":"388","author":"Huo","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJMoa2214403","article-title":"Trial of Endovascular Thrombectomy for Large Ischemic Strokes","volume":"388","author":"Sarraj","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/STROKEAHA.121.034268","article-title":"Endovascular Treatment of Acute Ischemic Stroke With the Penumbra System in Routine Practice: COMPLETE Registry Results","volume":"53","author":"Zaidat","year":"2022","journal-title":"Stroke"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1016\/j.wneu.2018.08.006","article-title":"Functional Independence after Stroke Thrombectomy Using Thrombolysis in Cerebral Infarction Grade 2c: A New Aim of Successful Revascularization","volume":"119","author":"Naragum","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1161\/STROKEAHA.122.039476","article-title":"Reperfusion Without Functional Independence in Late Presentation of Stroke With Large Vessel Occlusion","volume":"53","author":"Seker","year":"2022","journal-title":"Stroke"},{"key":"ref_71","first-page":"443","article-title":"Mechanical Thrombectomy for Acute Ischemic Stroke","volume":"29","author":"Sheth","year":"2023","journal-title":"Continuum"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/bc.bc_1_19","article-title":"Uric acid therapy for vasculoprotection in acute ischemic stroke","volume":"5","author":"Amaro","year":"2019","journal-title":"Brain Circ."},{"key":"ref_73","first-page":"554","article-title":"Exploration de l\u2019isch\u00e9mie c\u00e9r\u00e9brale in vivo: Application \u00e0 l\u2019\u00e9tude des neuroprotecteurs chez l\u2019animal [In vivo exploration of cerebral ischemia: Use of neuroprotective agents in animal studies]","volume":"57","author":"Lestage","year":"2002","journal-title":"Therapie"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.expneurol.2004.05.008","article-title":"Lost in translation: Taking neuroprotection from animal models to clinical trials","volume":"188","author":"Hoyte","year":"2004","journal-title":"Exp. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/jnnp-2020-324283","article-title":"The future of neuroprotection in stroke","volume":"92","author":"Chamorro","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/jcbfm.2010.184","article-title":"Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing","volume":"31","author":"Macleod","year":"2011","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuint.2016.12.007","article-title":"Targeting antioxidant enzyme expression as a therapeutic strategy for ischemic stroke","volume":"107","author":"Davis","year":"2017","journal-title":"Neurochem. Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3804979","DOI":"10.1155\/2018\/3804979","article-title":"Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy","volume":"2018","author":"Sun","year":"2018","journal-title":"Oxid Med. Cell. Longev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.nic.2018.06.008","article-title":"Reperfusion Changes After Stroke and Practical Approaches for Neuroprotection","volume":"28","author":"Choi","year":"2018","journal-title":"Neuroimaging Clin. N. Am."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/STROKEAHA.115.009960","article-title":"Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke","volume":"46","author":"Llull","year":"2015","journal-title":"Stroke"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcp.2019.04.002","article-title":"Uric acid treatment after stroke modulates the Kr\u00fcppel-like factor 2-VEGF-A axis to protect brain endothelial cell functions: Impact of hypertension","volume":"164","author":"Vila","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11011-020-00601-7","article-title":"Lower uric acid level may be associated with hemorrhagic transformation but not functional outcomes in patients with anterior circulation acute ischemic stroke undergoing endovascular thrombectomy","volume":"35","author":"Chen","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.21037\/atm-22-4494","article-title":"Increased serum uric acid level is associated with better outcome after endovascular treatment for acute ischemic stroke-a prospective cohort study","volume":"10","author":"Bai","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1747493016684354","article-title":"Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy","volume":"12","author":"Chamorro","year":"2017","journal-title":"Int. J. Stroke"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.2174\/1381612819666131230131454","article-title":"Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers","volume":"19","author":"Lyden","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuropharm.2017.09.021","article-title":"Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C","volume":"134 Pt B","author":"Amar","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ana.25383","article-title":"Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke","volume":"85","author":"Lyden","year":"2019","journal-title":"Ann. Neurol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Fraser, J.F., Pahwa, S., Maniskas, M., Michas, C., Martinez, M., Pennypacker, K.R., and Dornbos, D. (2023). Now that the door is open: An update on ischemic stroke pharmacotherapeutics for the neurointerventionalist. J. Neurointerv. Surg.","DOI":"10.1136\/jnis-2022-019293"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): A multicentre, double-blind, randomised controlled trial","volume":"395","author":"Hill","year":"2020","journal-title":"Lancet"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.25644","article-title":"Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study","volume":"87","author":"Kim","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Song, H.Y., Chung, J.I., Jalin, A.M.A., Ju, C., Pahk, K., Joung, C., Lee, S., Jin, S., Kim, B.S., and Lee, K.S. (2022). The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031403"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/joim.12576","article-title":"Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis","volume":"281","author":"Wahlgren","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1177\/0271678X17705259","article-title":"Intra-arterial verapamil post-thrombectomy is feasible, safe, and neuroprotective in stroke","volume":"37","author":"Fraser","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e045559","DOI":"10.1136\/bmjopen-2020-045559","article-title":"Efficacy and safety of butylphthalide for patients who had acute ischaemic stroke receiving intravenous thrombolysis or endovascular treatment (BAST trial): Study protocol for a randomised placebo-controlled trial","volume":"11","author":"Zhang","year":"2021","journal-title":"BMJ Open"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaneurol.2023.1871","article-title":"Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial","volume":"80","author":"Wang","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/STROKEAHA.120.031197","article-title":"Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial","volume":"52","author":"Xu","year":"2021","journal-title":"Stroke"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5853\/jos.2022.02453","article-title":"The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy","volume":"25","author":"Lee","year":"2023","journal-title":"J. Stroke"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1358\/dnp.2010.23.9.1513493","article-title":"Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke","volume":"23","author":"Cho","year":"2010","journal-title":"Drug News Perspect."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.tiv.2012.12.011","article-title":"Antioxidant properties of Neu2000 on mitochondrial free radicals and oxidative damage","volume":"27","author":"Visavadiya","year":"2013","journal-title":"Toxicol. Vitr. Int. J. Publ. Assoc. BIBRA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1161\/STROKEAHA.122.039649","article-title":"Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial","volume":"53","author":"Hong","year":"2022","journal-title":"Stroke"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/sj.jcbfm.9600418","article-title":"Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine","volume":"27","author":"Gwag","year":"2007","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/jcbfm.2010.231","article-title":"Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values","volume":"31","author":"Brea","year":"2011","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.106.603431","article-title":"Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke","volume":"115","author":"Caso","year":"2007","journal-title":"Circulation"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ymthe.2018.05.019","article-title":"TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models","volume":"26","author":"Moraga","year":"2018","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.omtn.2022.03.005","article-title":"First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers","volume":"28","author":"Ochoa","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jamaneurol.2023.1660","article-title":"Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1\/2 Randomized Clinical Trial","volume":"80","author":"Cotgreave","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/STROKEAHA.116.012727","article-title":"Endovascular Hypothermia in Acute Ischemic Stroke: Pilot Study of Selective Intra-Arterial Cold Saline Infusion","volume":"47","author":"Chen","year":"2016","journal-title":"Stroke"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1177\/0271678X18790139","article-title":"Safety, feasibility, and potential efficacy of intraarterial selective cooling infusion for stroke patients treated with mechanical thrombectomy","volume":"38","author":"Wu","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1186\/s40064-016-3654-7","article-title":"Protective roles of intra-arterial mild hypothermia and arterial thrombolysis in acute cerebral infarction","volume":"5","author":"Peng","year":"2016","journal-title":"Springerplus"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12035-021-02585-6","article-title":"Remote but not Distant: A Review on Experimental Models and Clinical Trials in Remote Ischemic Conditioning as Potential Therapy in Ischemic Stroke","volume":"59","author":"Mollet","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jama.2023.16893","article-title":"Remote Ischemic Conditioning for Acute Stroke: The RESIST Randomized Clinical Trial","volume":"330","author":"Blauenfeldt","year":"2023","journal-title":"JAMA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2022.13123","article-title":"Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke: The RICAMIS Randomized Clinical Trial","volume":"328","author":"Chen","year":"2022","journal-title":"JAMA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/2045-9912.191360","article-title":"Normobaric oxygen treatment in acute ischemic stroke: A clinical perspective","volume":"6","author":"Shi","year":"2016","journal-title":"Med. Gas. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000521027","article-title":"Normobaric Oxygen Therapy in Acute Stroke: A Systematic Review and Meta-Analysis","volume":"51","author":"Mahmood","year":"2022","journal-title":"Cerebrovasc. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/14737175.2017.1376657","article-title":"Normobaric hyperoxygenation: A potential neuroprotective therapy for acute ischemic stroke?","volume":"17","author":"Poli","year":"2017","journal-title":"Expert. Rev. Neurother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s13311-020-00979-3","article-title":"Adjuvant High-Flow Normobaric Oxygen After Mechanical Thrombectomy for Anterior Circulation Stroke: A Randomized Clinical Trial","volume":"18","author":"Cheng","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2:INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in Disease: Timing Is Everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1128\/MCB.23.23.8786-8794.2003","article-title":"Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway","volume":"23","author":"Kwak","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional Regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","article-title":"Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease","volume":"88 Pt B","author":"Tebay","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"25476","DOI":"10.1074\/jbc.M116.760249","article-title":"Nrf2 Transcription Factor Can Directly Regulate mTOR: Linking Cytoprotective Gene Expression to a Major Metabolic Regulator That Generates Redox Activity","volume":"291","author":"Bendavit","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.3112re3","article-title":"Stress-activated cap\u2019n\u2019collar transcription factors in aging and human disease","volume":"3","author":"Sykiotis","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: Pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4826724","DOI":"10.1155\/2017\/4826724","article-title":"The Nrf2\/Keap1\/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus","volume":"2017","author":"David","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10787-020-00785-5","article-title":"Dimethyl fumarate attenuates 2-VO-induced vascular dementia via activating the Nrf2 signaling pathway in rats","volume":"29","author":"Dhaliwal","year":"2021","journal-title":"Inflammopharmacology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"10321","DOI":"10.1523\/JNEUROSCI.4014-05.2005","article-title":"A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo","volume":"25","author":"Shih","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fncel.2018.00074","article-title":"Korean Red Ginseng Pretreatment Protects Against Long-Term Sensorimotor Deficits After Ischemic Stroke Likely Through Nrf2","volume":"12","author":"Liu","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12974-019-1406-7","article-title":"Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK\/GSK-3\u03b2\/Nrf2 signaling","volume":"16","author":"Duan","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"175516","DOI":"10.1016\/j.ejphar.2023.175516","article-title":"Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62\/Keap1\/Nrf2 pathway-mediated ferroptosis","volume":"944","author":"Wang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"115021","DOI":"10.1016\/j.jep.2022.115021","article-title":"Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K\/AKT\/Nrf2 and SLC7A11\/GPX4 signaling pathway after ischemia","volume":"289","author":"Fu","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"154729","DOI":"10.1016\/j.phymed.2023.154729","article-title":"Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice","volume":"113","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/cns.14130","article-title":"Srs11-92, a ferrostatin-1 analog, improves oxidative stress and neuroinflammation via Nrf2 signal following cerebral ischemia\/reperfusion injury","volume":"29","author":"Chen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bph.15961","article-title":"Icariside II preconditioning evokes robust neuroprotection against ischaemic stroke, by targeting Nrf2 and the OXPHOS\/NF-\u03baB\/ferroptosis pathway","volume":"180","author":"Gao","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"113142","DOI":"10.1016\/j.expneurol.2019.113142","article-title":"Ischemic preconditioning provides long-lasting neuroprotection against ischemic stroke: The role of Nrf2","volume":"325","author":"Yang","year":"2020","journal-title":"Exp. Neurol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/AIA.0000000000000402","article-title":"Acute ischemic stroke: Practical considerations for anesthesiologists","volume":"61","author":"Davis","year":"2023","journal-title":"Int. Anesthesiol. Clin."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/neurintsurg-2021-018300","article-title":"Stroke thrombectomy perioperative anesthetic and hemodynamic management","volume":"15","author":"Farag","year":"2023","journal-title":"J. Neurointerv. Surg."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1001\/jama.2016.16623","article-title":"Effect of Conscious Sedation vs General Anesthesia on Early Neurological Improvement Among Patients With Ischemic Stroke Undergoing Endovascular Thrombectomy: A Randomized Clinical Trial","volume":"316","author":"Uhlmann","year":"2016","journal-title":"JAMA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/STROKEAHA.117.016554","article-title":"General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke: The AnStroke Trial (Anesthesia During Stroke)","volume":"48","author":"Rentzos","year":"2017","journal-title":"Stroke"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2017.4474","article-title":"Effect of General Anesthesia and Conscious Sedation During Endovascular Therapy on Infarct Growth and Clinical Outcomes in Acute Ischemic Stroke: A Randomized Clinical Trial","volume":"75","author":"Simonsen","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1161\/STROKEAHA.117.017786","article-title":"Anesthesia-Related Outcomes for Endovascular Stroke Revascularization: A Systematic Review and Meta-Analysis","volume":"48","author":"Brinjikji","year":"2017","journal-title":"Stroke"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/neurintsurg-2018-013916","article-title":"Current evidence for anesthesia management during endovascular stroke therapy: Updated systematic review and meta-analysis","volume":"11","author":"Goyal","year":"2019","journal-title":"J. Neurointerv. Surg."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jama.2019.11455","article-title":"Association of General Anesthesia vs Procedural Sedation With Functional Outcome Among Patients With Acute Ischemic Stroke Undergoing Thrombectomy: A Systematic Review and Meta-analysis","volume":"322","author":"Simonsen","year":"2019","journal-title":"JAMA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/ALN.0000000000004142","article-title":"General Anesthesia versus Sedation, Both with Hemodynamic Control, during Intraarterial Treatment for Stroke: The GASS Randomized Trial","volume":"136","author":"Maurice","year":"2022","journal-title":"Anesthesiology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ANA.0000000000000042","article-title":"Society for Neuroscience in Anesthesiology and Critical Care Expert consensus statement: Anesthetic management of endovascular treatment for acute ischemic stroke*: Endorsed by the Society of NeuroInterventional Surgery and the Neurocritical Care Society","volume":"26","author":"Talke","year":"2014","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/01.STR.0000014509.11540.66","article-title":"Blood pressure and clinical outcomes in the International Stroke Trial","volume":"33","author":"Bath","year":"2002","journal-title":"Stroke"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2796.2003.01291.x","article-title":"U-shaped relationship between mortality and admission blood pressure in patients with acute stroke","volume":"255","author":"Vemmos","year":"2004","journal-title":"J. Intern. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.STR.0000109769.22917.B0","article-title":"Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome","volume":"35","author":"Castillo","year":"2004","journal-title":"Stroke"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1161\/STROKEAHA.115.010075","article-title":"Prognostic Significance of Short-Term Blood Pressure Variability in Acute Stroke: Systematic Review","volume":"46","author":"Manning","year":"2015","journal-title":"Stroke"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajem.2006.07.008","article-title":"Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States","volume":"25","author":"Qureshi","year":"2007","journal-title":"Am. J. Emerg. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1523\/JNEUROSCI.21-11-04032.2001","article-title":"Neurons of a limited subthalamic area mediate elevations in cortical cerebral blood flow evoked by hypoxia and excitation of neurons of the rostral ventrolateral medulla","volume":"21","author":"Golanov","year":"2001","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/01.STR.17.5.861","article-title":"Blood pressure course in patients with acute stroke and matched controls","volume":"17","author":"Britton","year":"1986","journal-title":"Stroke"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0404.2011.01515.x","article-title":"Dynamic cerebral autoregulation associates with infarct size and outcome after ischemic stroke","volume":"125","author":"Reinhard","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/STROKEAHA.116.016225","article-title":"Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands)","volume":"48","author":"Mulder","year":"2017","journal-title":"Stroke"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1161\/STROKEAHA.118.024286","article-title":"Decreases in Blood Pressure During Thrombectomy Are Associated With Larger Infarct Volumes and Worse Functional Outcome","volume":"50","author":"Petersen","year":"2019","journal-title":"Stroke"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/STROKEAHA.115.009808","article-title":"Hypotension During Endovascular Treatment of Ischemic Stroke Is a Risk Factor for Poor Neurological Outcome","volume":"46","author":"Rentzos","year":"2015","journal-title":"Stroke"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/jamaneurol.2020.3819","article-title":"Blood Pressure Thresholds During Endovascular Therapy in Ischemic Stroke-Reply","volume":"77","author":"Rasmussen","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s12028-021-01229-w","article-title":"Hemodynamic Status During Endovascular Stroke Treatment: Association of Blood Pressure with Functional Outcome","volume":"35","author":"Chen","year":"2021","journal-title":"Neurocritical Care"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000444098","article-title":"Lower Intraprocedural Systolic Blood Pressure Predicts Good Outcome in Patients Undergoing Endovascular Therapy for Acute Ischemic Stroke","volume":"4","author":"John","year":"2016","journal-title":"Interv. Neurol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e006167","DOI":"10.1161\/JAHA.117.006167","article-title":"Systolic Blood Pressure Within 24 Hours After Thrombectomy for Acute Ischemic Stroke Correlates with Outcome","volume":"6","author":"Mistry","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e019350","DOI":"10.1161\/JAHA.120.019350","article-title":"Adverse Outcomes Associated With Higher Mean Blood Pressure and Greater Blood Pressure Variability Immediately After Successful Embolectomy in Those With Acute Ischemic Stroke, and the Influence of Pretreatment Collateral Circulation Status","volume":"10","author":"Liu","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fneur.2019.00346","article-title":"Postreperfusion Blood Pressure Variability After Endovascular Thrombectomy Affects Outcomes in Acute Ischemic Stroke Patients With Poor Collateral Circulation","volume":"10","author":"Chang","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1161\/STROKEAHA.119.026889","article-title":"Blood Pressure after Endovascular Therapy for Ischemic Stroke (BEST): A Multicenter Prospective Cohort Study","volume":"50","author":"Mistry","year":"2019","journal-title":"Stroke"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/STROKEAHA.119.027549","article-title":"Blood Pressure Variability and Neurologic Outcome After Endovascular Thrombectomy: A Secondary Analysis of the BEST Study","volume":"51","author":"Mistry","year":"2020","journal-title":"Stroke"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42466-023-00238-8","article-title":"Blood pressure management in ischemic stroke patients undergoing mechanical thrombectomy","volume":"5","author":"Bowen","year":"2023","journal-title":"Neurol. Res. Pract."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/891\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:44:07Z","timestamp":1760103847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/2\/891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":166,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25020891"],"URL":"https:\/\/doi.org\/10.3390\/ijms25020891","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]}}}